Synthesis and Antiprotozoal Profile of 3,4,5-Trisubstituted Isoxazoles
- PMID: 34331350
- PMCID: PMC8485799
- DOI: 10.1002/open.202100141
Synthesis and Antiprotozoal Profile of 3,4,5-Trisubstituted Isoxazoles
Abstract
A series of 60 4-aminomethyl 5-aryl-3-substituted isoxazoles were synthesized by an efficient method and evaluated in vitro against Leishmania amazonensis and Trypanosoma cruzi, protozoa that cause the neglected tropical diseases leishmaniasis and Chagas disease, respectively. Thirteen compounds exhibited a selective index greater than 10. The series of 3-N-acylhydrazone isoxazole derivatives bearing the bithiophene core exhibited the best antiparasitic effects.
Keywords: N-acylhydrazone derivatives; antileishmanial drugs; antiprotozoal agents; cyclocondensation reactions; isoxazoles.
© 2021 The Authors. Published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Santos S. S., de Araújo R. V., Giarolla J., El Seoud O., Ferreira E. I., Int. J. Antimicrob. Agents 2020, 55, 105906. - PubMed
-
- Corpas-López V., Tabraue-Chávez M., Sixto-López Y., Panadero-Fajardo S., Alves De Lima Franco F., Domínguez-Seglar J. F., Morillas-Márquez F., Franco-Montalbán F., Díaz-Gavilán M., Correa-Basurto J., López-Viota J., López-Viota M., Pérez Del Palacio J., De La Cruz M., De Pedro N., Martín-Sánchez J., Gómez-Vidal J. A., J. Med. Chem. 2020, 63, 5734–5751. - PubMed
-
- None
-
- WHO, World Health Organization fact sheet on Leishmaniasis, https://www.who.int/en/news-room/fact-sheets/detail/leishmaniasis, 2 March 2020 (accessed on 5 April 2021);
-
- WHO, World Health Organization fact sheet on Chagas disease, https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(america..., 11 March 2020 (accessed on 5 April 2021).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical